Clinical Trial Update: Clinical Trial Using Bone Marrow-derived Mononuclear Cells for Spinal Cord Injury [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bone marrow-derived mononuclear cells for spinal cord injury, sponsored by Da Nang Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• bone marrow-derived mononuclear cells

Snippet

Sponsor: Da Nang Hospital | Conditions: Spinal Cord Injuries | Phase 2 | Status: UNKNOWN